Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study

Ryosuke Kitahata,1 Shinichiro Nakajima,1–4 Hiroyuki Uchida,1,3 Tetsu Hayashida,5 Maiko Takahashi,5 Shintaro Nio,1 Jinichi Hirano,1 Maki Nagaoka,1 Takefumi Suzuki,1 Hiromitsu Jinno,6 Yuko Kitagawa,5 Masaru Mimura1 1Psychopharmacology Research Program, Department of Neuropsychiatry, School...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kitahata R, Nakajima S, Uchida H, Hayashida T, Takahashi M, Nio S, Hirano J, Nagaoka M, Suzuki T, Jinno H, Kitagawa Y, Mimura M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/26bda0e4e056482d92fc7b316c380682
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:26bda0e4e056482d92fc7b316c380682
record_format dspace
spelling oai:doaj.org-article:26bda0e4e056482d92fc7b316c3806822021-12-02T02:47:30ZSelf-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study1178-2021https://doaj.org/article/26bda0e4e056482d92fc7b316c3806822017-10-01T00:00:00Zhttps://www.dovepress.com/self-rated-cognitive-functions-following-chemotherapy-in-patients-with-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Ryosuke Kitahata,1 Shinichiro Nakajima,1–4 Hiroyuki Uchida,1,3 Tetsu Hayashida,5 Maiko Takahashi,5 Shintaro Nio,1 Jinichi Hirano,1 Maki Nagaoka,1 Takefumi Suzuki,1 Hiromitsu Jinno,6 Yuko Kitagawa,5 Masaru Mimura1 1Psychopharmacology Research Program, Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan; 2Multimodal Imaging Group – Research Imaging Centre, 3Geriatric Mental Health Division, Centre for Addiction and Mental Health, 4Department of Psychiatry, University of Toronto, Toronto, Canada; 5Department of Surgery, School of Medicine, Keio University, 6Department of Surgery, School of Medicine, Teikyo University, Tokyo, Japan Purpose: The purpose of the study was to evaluate subjective (self-rated), family-rated, and objective (researcher-rated) cognitive functions in patients with breast cancer after chemotherapy.Method: We conducted a prospective study to trace self-rated cognitive functions in 30 patients with breast cancer at the completion of chemotherapy (T0) and 6 months later (T1). Subjective cognitive functions were assessed with Cognitive Failures Questionnaire (CFQ), Dysexecutive Questionnaire (DEX-S), and Everyday Memory Checklist (EMC-S) for attention, executive function, and episodic memory, respectively. Their family members also completed DEX-I and EMC-I for executive function and episodic memory, respectively. We also examined objective cognitive functions. Self-rated cognitive functions were compared with the normative data. They were compared between T0 and T1. We calculated correlation coefficients between self-rated and other cognitive functions.Results: At T0, 6 (20.0%) and 2 (6.7%) participants showed higher DEX-S and EMC-S scores than the normative data, respectively, while no participant had abnormal CFQ scores. At T1, DEX-S and EMC-S scores were normalized in 3 (50.0%) and 2 (100.0%) participants, respectively. No participant showed increases in CFQ scores. No changes were found in objective cognitive functions from T0 to T1. DEX-S and DEX-I or EMC-S and EMC-I scores were correlated at both T0 and T1, which did not survive multiple corrections. There was no association between subjective and objective cognitive functions.Conclusion: Impairments in subjective cognition may be transient after chemotherapy in patients with breast cancer. Furthermore, patients and their families appear to share similar prospects on their cognitive functions. Keywords: breast cancer, chemotherapy, subjective cognitive functionsKitahata RNakajima SUchida HHayashida TTakahashi MNio SHirano JNagaoka MSuzuki TJinno HKitagawa YMimura MDove Medical Pressarticlebreast cancerchemotherapysubjective cognitive functionsNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 13, Pp 2489-2496 (2017)
institution DOAJ
collection DOAJ
language EN
topic breast cancer
chemotherapy
subjective cognitive functions
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle breast cancer
chemotherapy
subjective cognitive functions
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Kitahata R
Nakajima S
Uchida H
Hayashida T
Takahashi M
Nio S
Hirano J
Nagaoka M
Suzuki T
Jinno H
Kitagawa Y
Mimura M
Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study
description Ryosuke Kitahata,1 Shinichiro Nakajima,1–4 Hiroyuki Uchida,1,3 Tetsu Hayashida,5 Maiko Takahashi,5 Shintaro Nio,1 Jinichi Hirano,1 Maki Nagaoka,1 Takefumi Suzuki,1 Hiromitsu Jinno,6 Yuko Kitagawa,5 Masaru Mimura1 1Psychopharmacology Research Program, Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan; 2Multimodal Imaging Group – Research Imaging Centre, 3Geriatric Mental Health Division, Centre for Addiction and Mental Health, 4Department of Psychiatry, University of Toronto, Toronto, Canada; 5Department of Surgery, School of Medicine, Keio University, 6Department of Surgery, School of Medicine, Teikyo University, Tokyo, Japan Purpose: The purpose of the study was to evaluate subjective (self-rated), family-rated, and objective (researcher-rated) cognitive functions in patients with breast cancer after chemotherapy.Method: We conducted a prospective study to trace self-rated cognitive functions in 30 patients with breast cancer at the completion of chemotherapy (T0) and 6 months later (T1). Subjective cognitive functions were assessed with Cognitive Failures Questionnaire (CFQ), Dysexecutive Questionnaire (DEX-S), and Everyday Memory Checklist (EMC-S) for attention, executive function, and episodic memory, respectively. Their family members also completed DEX-I and EMC-I for executive function and episodic memory, respectively. We also examined objective cognitive functions. Self-rated cognitive functions were compared with the normative data. They were compared between T0 and T1. We calculated correlation coefficients between self-rated and other cognitive functions.Results: At T0, 6 (20.0%) and 2 (6.7%) participants showed higher DEX-S and EMC-S scores than the normative data, respectively, while no participant had abnormal CFQ scores. At T1, DEX-S and EMC-S scores were normalized in 3 (50.0%) and 2 (100.0%) participants, respectively. No participant showed increases in CFQ scores. No changes were found in objective cognitive functions from T0 to T1. DEX-S and DEX-I or EMC-S and EMC-I scores were correlated at both T0 and T1, which did not survive multiple corrections. There was no association between subjective and objective cognitive functions.Conclusion: Impairments in subjective cognition may be transient after chemotherapy in patients with breast cancer. Furthermore, patients and their families appear to share similar prospects on their cognitive functions. Keywords: breast cancer, chemotherapy, subjective cognitive functions
format article
author Kitahata R
Nakajima S
Uchida H
Hayashida T
Takahashi M
Nio S
Hirano J
Nagaoka M
Suzuki T
Jinno H
Kitagawa Y
Mimura M
author_facet Kitahata R
Nakajima S
Uchida H
Hayashida T
Takahashi M
Nio S
Hirano J
Nagaoka M
Suzuki T
Jinno H
Kitagawa Y
Mimura M
author_sort Kitahata R
title Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study
title_short Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study
title_full Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study
title_fullStr Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study
title_full_unstemmed Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study
title_sort self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/26bda0e4e056482d92fc7b316c380682
work_keys_str_mv AT kitahatar selfratedcognitivefunctionsfollowingchemotherapyinpatientswithbreastcancera6monthprospectivestudy
AT nakajimas selfratedcognitivefunctionsfollowingchemotherapyinpatientswithbreastcancera6monthprospectivestudy
AT uchidah selfratedcognitivefunctionsfollowingchemotherapyinpatientswithbreastcancera6monthprospectivestudy
AT hayashidat selfratedcognitivefunctionsfollowingchemotherapyinpatientswithbreastcancera6monthprospectivestudy
AT takahashim selfratedcognitivefunctionsfollowingchemotherapyinpatientswithbreastcancera6monthprospectivestudy
AT nios selfratedcognitivefunctionsfollowingchemotherapyinpatientswithbreastcancera6monthprospectivestudy
AT hiranoj selfratedcognitivefunctionsfollowingchemotherapyinpatientswithbreastcancera6monthprospectivestudy
AT nagaokam selfratedcognitivefunctionsfollowingchemotherapyinpatientswithbreastcancera6monthprospectivestudy
AT suzukit selfratedcognitivefunctionsfollowingchemotherapyinpatientswithbreastcancera6monthprospectivestudy
AT jinnoh selfratedcognitivefunctionsfollowingchemotherapyinpatientswithbreastcancera6monthprospectivestudy
AT kitagaway selfratedcognitivefunctionsfollowingchemotherapyinpatientswithbreastcancera6monthprospectivestudy
AT mimuram selfratedcognitivefunctionsfollowingchemotherapyinpatientswithbreastcancera6monthprospectivestudy
_version_ 1718402150188449792